{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:45:59Z","timestamp":1782715559422,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project","award":["2024ZL222"],"award-info":[{"award-number":["2024ZL222"]}]},{"name":"Zhejiang Provincial Health Science and Technology Program Project","award":["2022KY479"],"award-info":[{"award-number":["2022KY479"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11064-026-04790-y","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T08:11:37Z","timestamp":1779437497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b2-Asarone, Tenuifolin, and YuanZhi Decoction Restore Cognitive Function and Modulate GRIN2B-Associated Autophagy in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"51","author":[{"given":"Haimin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feijun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5232-4782","authenticated-orcid":false,"given":"Zhifeng","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"4790_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X (2025) Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell 16:83\u2013120","journal-title":"Protein Cell"},{"key":"4790_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1515\/revneuro-2017-0063","volume":"29","author":"AB Reiss","year":"2018","unstructured":"Reiss AB, Arain HA, Stecker MM, Siegart NM, Kasselman LJ (2018) Amyloid toxicity in Alzheimer\u2019s disease. Rev Neurosci 29:613\u2013627","journal-title":"Rev Neurosci"},{"key":"4790_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","volume":"21","author":"R van der Ossenkoppele","year":"2022","unstructured":"van der Ossenkoppele R, Hansson O (2022) Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials. Lancet Neurol 21:726\u2013734","journal-title":"Lancet Neurol"},{"key":"4790_CR4","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.24272\/j.issn.2095-8137.2022.289","volume":"43","author":"ZY Chen","year":"2022","unstructured":"Chen ZY, Zhang Y (2022) Animal models of Alzheimer\u2019s disease: Applications, evaluation, and perspectives. Zool Res 43:1026\u20131040","journal-title":"Zool Res"},{"key":"4790_CR5","doi-asserted-by":"publisher","first-page":"102599","DOI":"10.1016\/j.arr.2024.102599","volume":"104","author":"HK Krishnamurthy","year":"2025","unstructured":"Krishnamurthy HK, Jayaraman V, Krishna K, Wang T, Bei K, Changalath C, Rajasekaran JJ (2025) An overview of the genes and biomarkers in Alzheimer\u2019s disease. Ageing Res Rev 104:102599","journal-title":"Ageing Res Rev"},{"key":"4790_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20:148\u2013160","journal-title":"Nat Rev Neurosci"},{"key":"4790_CR7","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.24272\/j.issn.2095-8137.2023.294","volume":"44","author":"XW Zhang","year":"2023","unstructured":"Zhang XW, Zhu XX, Tang DS, Lu JH (2023) Targeting autophagy in Alzheimer\u2019s disease: Animal models and mechanisms. Zool Res 44:1132\u20131145","journal-title":"Zool Res"},{"key":"4790_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.14283\/jpad.2023.3","volume":"10","author":"Z Qiu","year":"2023","unstructured":"Qiu Z, Zhang H, Xia M, Gu J, Guo K, Wang H, Miao C (2023) Programmed Death of Microglia in Alzheimer\u2019s Disease: Autophagy, Ferroptosis, and Pyroptosis. J Prev Alzheimers Dis 10:95\u2013103","journal-title":"J Prev Alzheimers Dis"},{"key":"4790_CR9","doi-asserted-by":"crossref","unstructured":"Reddy PH, Oliver DM (2019) Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer\u2019s Disease. Cells 8","DOI":"10.3390\/cells8050488"},{"key":"4790_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11064-025-04490-z","volume":"50","author":"Q Yu","year":"2025","unstructured":"Yu Q, Li L, Yu S, Han J, Cheng Q, Cui Z, Chen H, Li M, Lu Z (2025) Mitochondrial Damage and Autophagy Dysregulation in Alzheimer\u2019s Disease: Mechanisms and Therapeutic Opportunities. Neurochem Res 50:251","journal-title":"Neurochem Res"},{"key":"4790_CR11","doi-asserted-by":"publisher","first-page":"1006089","DOI":"10.3389\/fnagi.2022.1006089","volume":"14","author":"R Butler","year":"2022","unstructured":"Butler R, Bradford D, Rodgers KE (2022) Analysis of shared underlying mechanism in neurodegenerative disease. Front Aging Neurosci 14:1006089","journal-title":"Front Aging Neurosci"},{"key":"4790_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2217\/epi-2018-0127","volume":"11","author":"HA Fachim","year":"2019","unstructured":"Fachim HA, Loureiro CM, Corsi-Zuelli F, Shuhama R, Louzada-Junior P, Menezes PR, Dalton CF, Del-Ben CM, Reynolds GP (2019) GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function. Epigenomics 11:401\u2013410","journal-title":"Epigenomics"},{"key":"4790_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jphs.2016.10.002","volume":"132","author":"C Hu","year":"2016","unstructured":"Hu C, Chen W, Myers SJ, Yuan H, Traynelis SF (2016) Human GRIN2B variants in neurodevelopmental disorders. J Pharmacol Sci 132:115\u2013121","journal-title":"J Pharmacol Sci"},{"key":"4790_CR14","doi-asserted-by":"publisher","first-page":"111147","DOI":"10.1016\/j.jbc.2026.111147","volume":"302","author":"TM Benske","year":"2026","unstructured":"Benske TM, Williams MP, Zhang PP, Palumbo AJ, Mu TW (2026) A GluN2B disease-associated variant promotes the degradation of NMDA receptors via autophagy. J Biol Chem 302:111147","journal-title":"J Biol Chem"},{"key":"4790_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.parkreldis.2015.11.016","volume":"22","author":"A Hassan","year":"2016","unstructured":"Hassan A, Heckman MG, Ahlskog JE, Wszolek ZK, Serie DJ, Uitti RJ, van Gerpen JA, Okun MS, Rayaprolu S, Ross OA (2016) Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms. Parkinsonism Relat Disord 22:102\u2013105","journal-title":"Parkinsonism Relat Disord"},{"key":"4790_CR16","first-page":"533","volume":"121","author":"V Andreoli","year":"2014","unstructured":"Andreoli V, De Marco EV, Trecroci F, Cittadella R, Di Palma G, Gambardella A (2014) Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer\u2019s disease. J Neural Transm (Vienna) 121:533\u2013542","journal-title":"J Neural Transm (Vienna)"},{"key":"4790_CR17","doi-asserted-by":"publisher","first-page":"114896","DOI":"10.1016\/j.bbr.2024.114896","volume":"463","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhou J, Zhang B, Xu Z, Wang H, Sun Q, Wang N (2024) Inhibitory effects of beta-asarone on lncRNA BACE1-mediated induction of autophagy in a model of Alzheimer\u2019s disease. Behav Brain Res 463:114896","journal-title":"Behav Brain Res"},{"key":"4790_CR18","doi-asserted-by":"publisher","first-page":"155215","DOI":"10.1016\/j.phymed.2023.155215","volume":"123","author":"Z Ning","year":"2024","unstructured":"Ning Z, Zhong X, Wu Y, Wang Y, Hu D, Wang K, Deng M (2024) beta-asarone improves cognitive impairment and alleviates autophagy in mice with vascular dementia via the cAMP\/PKA\/CREB pathway. Phytomedicine 123:155215","journal-title":"Phytomedicine"},{"key":"4790_CR19","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1002\/ptr.7930","volume":"37","author":"C Li","year":"2023","unstructured":"Li C, Gao F, Qu Y, Zhao P, Wang X, Zhu G (2023) Tenuifolin in the prevention of Alzheimer\u2019s disease-like phenotypes: Investigation of the mechanisms from the perspectives of calpain system, ferroptosis, and apoptosis. Phytother Res 37:4621\u20134638","journal-title":"Phytother Res"},{"key":"4790_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/JAD-200077","volume":"76","author":"S Chen","year":"2020","unstructured":"Chen S, Jia J (2020) Tenuifolin Attenuates Amyloid-\u03b242-Induced Neuroinflammation in Microglia Through the NF-\u03baB Signaling Pathway. J Alzheimers Dis 76:195\u2013205","journal-title":"J Alzheimers Dis"},{"key":"4790_CR21","doi-asserted-by":"publisher","first-page":"1431894","DOI":"10.3389\/fphar.2024.1431894","volume":"15","author":"S Li","year":"2024","unstructured":"Li S, Hou Z, Ye T, Song X, Hu X, Chen J (2024) Saponin components in Polygala tenuifolia as potential candidate drugs for treating dementia. Front Pharmacol 15:1431894","journal-title":"Front Pharmacol"},{"key":"4790_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neulet.2019.04.045","volume":"705","author":"L Wang","year":"2019","unstructured":"Wang L, Jin G, Yu H, Li Q, Yang H (2019) Protective effect of Tenuifolin against Alzheimer\u2019s disease. Neurosci Lett 705:195\u2013201","journal-title":"Neurosci Lett"},{"key":"4790_CR23","doi-asserted-by":"crossref","unstructured":"Liu Y, Huang X, Chen W, Chen Y, Wang N, Wu X (2020) The Effects of Yuan-Zhi Decoction and Its Active Ingredients in Both In Vivo and In Vitro Models of Chronic Cerebral Hypoperfusion by Regulating the Levels of Abeta and Autophagy. Evid Based Complement Alternat Med 2020:6807879","DOI":"10.1155\/2020\/6807879"},{"key":"4790_CR24","doi-asserted-by":"publisher","first-page":"893244","DOI":"10.3389\/fphar.2022.893244","volume":"13","author":"Q Wu","year":"2022","unstructured":"Wu Q, Li X, Jiang XW, Yao D, Zhou LJ, Xu ZH, Wang N, Zhao QC, Zhang Z (2022) Yuan-Zhi decoction in the treatment of Alzheimer\u2019s disease: An integrated approach based on chemical profiling, network pharmacology, molecular docking and experimental evaluation. Front Pharmacol 13:893244","journal-title":"Front Pharmacol"},{"key":"4790_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10571-015-0226-2","volume":"36","author":"C Yang","year":"2016","unstructured":"Yang C, Li X, Mo Y, Liu S, Zhao L, Ma X, Fang Z, Chen J, Chen Y, Yu X, Fang S, Zhang Y, Xian S, Wang Q (2016) \u03b2-Asarone Mitigates Amyloidosis and Downregulates RAGE in a Transgenic Mouse Model of Alzheimer\u2019s Disease. Cell Mol Neurobiol 36:121\u2013130","journal-title":"Cell Mol Neurobiol"},{"key":"4790_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fninf.2019.00013","volume":"13","author":"W Zhao","year":"2019","unstructured":"Zhao W, Wang X, Yin C, He M, Li S, Han Y (2019) Trajectories of the Hippocampal Subfields Atrophy in the Alzheimer\u2019s Disease: A Structural Imaging Study. Front Neuroinform 13:13","journal-title":"Front Neuroinform"},{"key":"4790_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13195-025-01768-w","volume":"17","author":"MMA Bouwman","year":"2025","unstructured":"Bouwman MMA, Frigerio I, Lin CP, van de Reijner N, Jonkman LE (2025) Hippocampal subfields: volume, neuropathological vulnerability and cognitive decline in Alzheimer\u2019s and Parkinson\u2019s disease. Alzheimers Res Ther 17:121","journal-title":"Alzheimers Res Ther"},{"key":"4790_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13024-023-00605-8","volume":"18","author":"F Gonzalez-Ortiz","year":"2023","unstructured":"Gonzalez-Ortiz F, Kac PR, Brum WS, Zetterberg H, Blennow K, Karikari TK (2023) Plasma phospho-tau in Alzheimer\u2019s disease: towards diagnostic and therapeutic trial applications. Mol Neurodegener 18:18","journal-title":"Mol Neurodegener"},{"key":"4790_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ibneur.2024.11.005","volume":"17","author":"S Bang","year":"2024","unstructured":"Bang S, Song JK, Lee KH (2024) Hyperphosphorylated tau targeting human serum albumin Fusion protein as therapeutics for Alzheimer\u2019s diseases. IBRO Neurosci Rep 17:423\u2013430","journal-title":"IBRO Neurosci Rep"},{"key":"4790_CR30","doi-asserted-by":"publisher","first-page":"937333","DOI":"10.3389\/fphar.2022.937333","volume":"13","author":"Z Chen","year":"2022","unstructured":"Chen Z, Yang Y, Han Y, Wang X (2022) Neuroprotective Effects and Mechanisms of Senegenin, an Effective Compound Originated From the Roots of Polygala Tenuifolia. Front Pharmacol 13:937333","journal-title":"Front Pharmacol"},{"key":"4790_CR31","doi-asserted-by":"crossref","unstructured":"Shen X, Dai X, He Y, Wen C, Zhang Q (2022) Determination of Senegenin and Tenuifolin in Mouse Blood by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry and Their Pharmacokinetics. Int J Anal Chem 2022:3401355","DOI":"10.1155\/2022\/3401355"},{"key":"4790_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2174\/156802606776894456","volume":"6","author":"I Borza","year":"2006","unstructured":"Borza I, Domany G (2006) NR2B selective NMDA antagonists: the evolution of the ifenprodil-type pharmacophore. Curr Top Med Chem 6:687\u2013695","journal-title":"Curr Top Med Chem"},{"key":"4790_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","volume":"56","author":"DO Seo","year":"2024","unstructured":"Seo DO, Holtzman DM (2024) Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies. Exp Mol Med 56:86\u201394","journal-title":"Exp Mol Med"},{"key":"4790_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exger.2017.10.029","volume":"101","author":"T Shwe","year":"2018","unstructured":"Shwe T, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2018) Role of D-galactose-induced brain aging and its potential used for therapeutic interventions. Exp Gerontol 101:13\u201336","journal-title":"Exp Gerontol"},{"key":"4790_CR35","doi-asserted-by":"publisher","first-page":"e0183565","DOI":"10.1371\/journal.pone.0183565","volume":"12","author":"S Kenawy","year":"2017","unstructured":"Kenawy S, Hegazy R, Hassan A, El-Shenawy S, Gomaa N, Zaki H, Attia A (2017) Involvement of insulin resistance in D-galactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin. PLoS ONE 12:e0183565","journal-title":"PLoS ONE"},{"key":"4790_CR36","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s10787-022-00973-5","volume":"30","author":"WW Ibrahim","year":"2022","unstructured":"Ibrahim WW, Kamel AS, Wahid A, Abdelkader NF (2022) Dapagliflozin as an autophagic enhancer via LKB1\/AMPK\/SIRT1 pathway in ovariectomized\/D-galactose Alzheimer\u2019s rat model. Inflammopharmacology 30:2505\u20132520","journal-title":"Inflammopharmacology"},{"key":"4790_CR37","doi-asserted-by":"publisher","first-page":"e0266331","DOI":"10.1371\/journal.pone.0266331","volume":"17","author":"HC Kuo","year":"2022","unstructured":"Kuo HC, Tong SY, Chao MW, Tseng CY (2022) Ganoderma tsugae prevents cognitive impairment and attenuates oxidative damage in d-galactose-induced aging in the rat brain. PLoS ONE 17:e0266331","journal-title":"PLoS ONE"},{"key":"4790_CR38","doi-asserted-by":"crossref","unstructured":"Balakrishnan R, Cho DY, Kim IS, Seol SH, Choi DK (2022) Molecular Mechanisms and Therapeutic Potential of alpha- and beta-Asarone in the Treatment of Neurological Disorders. Antioxidants (Basel) 11","DOI":"10.3390\/antiox11020281"},{"key":"4790_CR39","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.cell.2021.03.048","volume":"184","author":"M Bourdenx","year":"2021","unstructured":"Bourdenx M, Martin-Segura A, Scrivo A, Rodriguez-Navarro JA, Kaushik S, Tasset I, Diaz A, Storm NJ, Xin Q, Juste YR, Stevenson E, Luengo E, Clement CC, Choi SJ, Krogan NJ, Mosharov EV, Santambrogio L, Grueninger F, Collin L, Swaney DL, Sulzer D, Gavathiotis E, Cuervo AM (2021) Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome. Cell 184:2696\u20132714e2625","journal-title":"Cell"},{"key":"4790_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2024.09.015","volume":"113","author":"JE Palmer","year":"2025","unstructured":"Palmer JE, Wilson N, Son SM, Obrocki P, Wrobel L, Rob M, Takla M, Korolchuk VI, Rubinsztein DC (2025) Autophagy, aging, and age-related neurodegeneration. Neuron 113:29\u201348","journal-title":"Neuron"},{"key":"4790_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrn3961","volume":"16","author":"FM Menzies","year":"2015","unstructured":"Menzies FM, Fleming A, Rubinsztein DC (2015) Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci 16:345\u2013357","journal-title":"Nat Rev Neurosci"},{"key":"4790_CR42","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1523\/JNEUROSCI.0640-10.2010","volume":"30","author":"JL Brigman","year":"2010","unstructured":"Brigman JL, Wright T, Talani G, Prasad-Mulcare S, Jinde S, Seabold GK, Mathur P, Davis MI, Bock R, Gustin RM, Colbran RJ, Alvarez VA, Nakazawa K, Delpire E, Lovinger DM, Holmes A (2010) Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. J Neurosci 30:4590\u20134600","journal-title":"J Neurosci"},{"key":"4790_CR43","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.neuron.2008.09.039","volume":"60","author":"J von Engelhardt","year":"2008","unstructured":"von Engelhardt J, Doganci B, Jensen V, Hvalby O, Gongrich C, Taylor A, Barkus C, Sanderson DJ, Rawlins JN, Seeburg PH, Bannerman DM, Monyer H (2008) Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks. Neuron 60:846\u2013860","journal-title":"Neuron"},{"key":"4790_CR44","doi-asserted-by":"publisher","first-page":"115409","DOI":"10.1016\/j.jep.2022.115409","volume":"295","author":"Y Tian","year":"2022","unstructured":"Tian Y, Qi Y, Cai H, Xu M, Zhang Y (2022) Senegenin alleviates Abeta(1-42) induced cell damage through triggering mitophagy. J Ethnopharmacol 295:115409","journal-title":"J Ethnopharmacol"},{"key":"4790_CR45","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1007\/s12035-022-03014-y","volume":"59","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhou W, Li J, Qiu Z, Wang X, Xu H, Wang H, Lu D, Qi R (2022) Senegenin Rescues PC12 Cells with Oxidative Damage Through Inhibition of Ferroptosis. Mol Neurobiol 59:6983\u20136992","journal-title":"Mol Neurobiol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04790-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:03:48Z","timestamp":1782713028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04790-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4790"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04790-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The animal experiments in this study were conducted following the ARRIVE guidelines and approved by the Animal Ethical Care Committee of Qiqihar Medical University (Approval No. QMU-AECC-2024-65).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}],"article-number":"170"}}